Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Use of Antipsychotics on Dementia Patients As “Chemical Restraints” Increased During Pandemic: Study Even though rates of dementia diagnoses dropped worldwide during the COVID-19 pandemic, rates of prescribing antipsychotics to those patients increased, raising fears the drugs are being used as chemical restraints. March 6, 2023 Martha Garcia Add Your Comments During the COVID-19 pandemic, the rates of antipsychotic drugs prescribed to sedate dementia patients skyrocketed, according to a new study which highlights concerns about inappropriate use of the medications as a form of “chemical restraint”, especially in nursing homes and long-term care facilities. In a report published in the medical journal JAMA Psychiatry, researchers warn that prescriptions for antipsychotics like Abilify and Zyprexa not only increased dramatically during the early days of the pandemic, but rates did not return to prior levels even after the acute phase of the pandemic was over. Researchers suggest the pandemic conditions worsened mental and behavioral health, and psychological conditions for dementia patients. However, critics also warn the increase in antipsychotic use may point to inappropriate use of the medications to chemically restrain certain patients, which is a controversial practice that has long been known to pose unintended health risks, including an increased risk of death. Chemical Restraint Concerns Chemical restraint involves the unnecessary use of antipsychotic medications on elderly patients and nursing home residents to sedate “unruly” patients. The practice has drawn the attention of drug regulators and safety experts, since the drugs often have no medical purpose and simply calm patients to make them easier for healthcare workers to care for them. It offers no benefit to the patient, but side effects of the antipsychotics may lead to serious complications. Do You Know about… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION In this latest study, a team of international researchers conducted a multinational network study using electronic health records and claims data from eight databases in six countries including France, Germany, Italy, South Korea, the U.K., and the U.S. The study included individuals 65 years and older from 2016 to 2021. Overall, the study involved 857,000 people diagnosed with dementia. According to the findings, the rates of antipsychotic medication prescribing among dementia patients increased by 43% after the pandemic began, compared to the same time period in 2019. The greatest increases occurred in May 2020 in South Korea, and June 2020 in the U.K. Prescriptions more than doubled in those countries during the early pandemic period. Concurrently, diagnoses of dementia dropped in all countries during that same early pandemic time period, with the exception of Germany. The U.S. had significant decreases in the diagnosis of dementia during the early pandemic months from April to June 2020 and remained low in the U.S. through 2021. Yet, despite reductions in dementia diagnoses, rates of antipsychotic prescribing in dementia patients increased in all countries during the pandemic and remained high in 2021. Antipsychotic drugs like Abilify, Haloperidol, and Rexulti, are prescribed for contains like schizophrenia and other mental disorders. But in some cases, healthcare providers give these drugs, which decrease motor function, increase drowsiness and can increase dizziness, to elderly patients with dementia to calm them and make it easier to care for them. Recently, the White House called on the Centers for Medicare & Medicaid Services to investigate the inappropriate practice of chemical restraint among nursing home residents. Off-label use of antipsychotics can lead to stroke, heart attack, diabetes, Parkinson’s disease, and falls. Researchers call for caregivers to be better trained in problem-solving, which can have a greater positive effect on patient behavior than drug prescribing or chemical restraint practices, like the ones seen during and following the pandemic. “These findings suggest that the pandemic disrupted the care of people living with dementia and that the development of intervention strategies is needed to ensure the quality of care,” the researchers wrote. Tags: Antipsychotics, Chemical Restraints, Dementia, Elder Abuse, Nursing Homes Image Credit: | More Lawsuit Stories Galaxy Gas Lawsuit Filed Over Nitrous Oxide Addiction and Brain Injury Risks April 24, 2025 500 Suboxone Tooth Decay Cases Randomly Selected for Bellwether Record Collection Pool April 24, 2025 Living in Close Proximity to Oil and Gas Wells Increases Childhood Leukemia Risk: Study April 24, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Galaxy Gas Lawsuit Filed Over Nitrous Oxide Addiction and Brain Injury Risks (Posted: today) A class action lawsuit has been filed against Galaxy Gas and several associated companies, alleging the product is marketed to teens using sweet flavors and deceptive safety claims, leading to widespread addiction and neurological injuries. MORE ABOUT: NITROUS OXIDE LAWSUITGalaxy Gas Seeks Dismissal of Lawsuit Over Nitrous Oxide Death (04/21/2025)Nitrous Oxide Class Action Lawsuit Filed Over Fatal Side Effects of Flavored Gas Sold In Vape Shops (04/02/2025) 500 Suboxone Tooth Decay Cases Randomly Selected for Bellwether Record Collection Pool (Posted: today) A federal judge has randomly selected a group of 500 Suboxone tooth decay lawsuits to go through case-specific discovery and further workup, which may eventually be eligible for early bellwether trials. MORE ABOUT: SUBOXONE TOOTH DECAY LAWSUITStatus of Suboxone Tooth Loss Lawsuits To Be Reviewed at MDL Conference (04/16/2025)Prenatal Opioid Exposure May Result in Smaller Brains Among Newborns: Study (04/14/2025)Suboxone Lawsuit Filing Deadline Nears for Many Tooth Decay Claims in 3-Year SOL States (04/07/2025) Hair Relaxer Lawyers To Meet With MDL Judge Amid “Contentious” Disputes Over Bellwether Discovery Plans (Posted: yesterday) Lawyers involved in the federal hair relaxer lawsuits submitted a status report in advance of an MDL status conference tomorrow, highlighting a number of ongoing disputes over Defendant Fact Sheets and a potential Science Day. MORE ABOUT: HAIR RELAXER LAWSUITMore Than 12,000 Hair Relaxer Cancer Lawsuits Filed Against L’Oreal, Other Cosmetics Companies (04/17/2025)Uterine and Endometrial Cancer Caused by Hair Relaxer Products: Lawsuit (03/25/2025)Schedule for Hair Relaxer Lawsuit Bellwether Trials Outlined by MDL Judge (03/13/2025)
500 Suboxone Tooth Decay Cases Randomly Selected for Bellwether Record Collection Pool April 24, 2025
Living in Close Proximity to Oil and Gas Wells Increases Childhood Leukemia Risk: Study April 24, 2025
Galaxy Gas Lawsuit Filed Over Nitrous Oxide Addiction and Brain Injury Risks (Posted: today) A class action lawsuit has been filed against Galaxy Gas and several associated companies, alleging the product is marketed to teens using sweet flavors and deceptive safety claims, leading to widespread addiction and neurological injuries. MORE ABOUT: NITROUS OXIDE LAWSUITGalaxy Gas Seeks Dismissal of Lawsuit Over Nitrous Oxide Death (04/21/2025)Nitrous Oxide Class Action Lawsuit Filed Over Fatal Side Effects of Flavored Gas Sold In Vape Shops (04/02/2025)
500 Suboxone Tooth Decay Cases Randomly Selected for Bellwether Record Collection Pool (Posted: today) A federal judge has randomly selected a group of 500 Suboxone tooth decay lawsuits to go through case-specific discovery and further workup, which may eventually be eligible for early bellwether trials. MORE ABOUT: SUBOXONE TOOTH DECAY LAWSUITStatus of Suboxone Tooth Loss Lawsuits To Be Reviewed at MDL Conference (04/16/2025)Prenatal Opioid Exposure May Result in Smaller Brains Among Newborns: Study (04/14/2025)Suboxone Lawsuit Filing Deadline Nears for Many Tooth Decay Claims in 3-Year SOL States (04/07/2025)
Hair Relaxer Lawyers To Meet With MDL Judge Amid “Contentious” Disputes Over Bellwether Discovery Plans (Posted: yesterday) Lawyers involved in the federal hair relaxer lawsuits submitted a status report in advance of an MDL status conference tomorrow, highlighting a number of ongoing disputes over Defendant Fact Sheets and a potential Science Day. MORE ABOUT: HAIR RELAXER LAWSUITMore Than 12,000 Hair Relaxer Cancer Lawsuits Filed Against L’Oreal, Other Cosmetics Companies (04/17/2025)Uterine and Endometrial Cancer Caused by Hair Relaxer Products: Lawsuit (03/25/2025)Schedule for Hair Relaxer Lawsuit Bellwether Trials Outlined by MDL Judge (03/13/2025)